Genesis HealthCare (GEN) Tops Q3 EPS by 12c; Guidance Reaffirmed

Genesis HealthCare (NYSE: GEN) reported Q3 EPS of ($0.28), $0.12 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.39 billion.Genesis HealthCare reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance